Literature DB >> 18930144

Combined effects of prenatal inhibition of vasculogenesis and neurogenesis on rat brain development.

Q Y Fan1, S Ramakrishna, N Marchi, Vincent Fazio, Kerri Hallene, D Janigro.   

Abstract

Malformations of cortical development (MCD) are one of the most common causes of neurological disabilities including autism and epilepsy. To disrupt cortical formation, methylazoxymethanol (MAM) or thalidomide (THAL) has been used to affect neurogenesis or vasculogenesis. Although previous models of MCD have been useful, these models primarily attack a single aspect of cortical development. We hypothesized that simultaneous prenatal exposure to MAM or THAL will lead to the development of a novel and specific type of brain maldevelopment. Rats were prenatally exposed to MAM and THAL. At early postnatal days, brains displayed abnormal ventricular size and hemispheric asymmetry due to altered brain water homeostasis. The postnatal brain was also characterized by gliosis in regions of focal leakage of the blood brain barrier. These morphological abnormalities gradually disappeared at adult stages. Although the adult MAM-THAL rats showed normal cortical morphology, abnormal hippocampal connectivity and mossy fiber sprouting persisted well into adulthood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930144      PMCID: PMC3900291          DOI: 10.1016/j.nbd.2008.09.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  35 in total

Review 1.  Common mechanisms of nerve and blood vessel wiring.

Authors:  Peter Carmeliet; Marc Tessier-Lavigne
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

Review 2.  Etiology of infantile autism: a review of recent advances in genetic and neurobiological research.

Authors:  G Trottier; L Srivastava; C D Walker
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

Review 3.  Cortical malformations and epilepsy: new insights from animal models.

Authors:  N Chevassus-au-Louis; S C Baraban; J L Gaïarsa; Y Ben-Ari
Journal:  Epilepsia       Date:  1999-07       Impact factor: 5.864

4.  Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human developmental brain dysgeneses.

Authors:  C Colacitti; G Sancini; S DeBiasi; S Franceschetti; A Caputi; C Frassoni; F Cattabeni; G Avanzini; R Spreafico; M Di Luca; G Battaglia
Journal:  J Neuropathol Exp Neurol       Date:  1999-01       Impact factor: 3.685

5.  Mossy fiber sprouting after recurrent seizures during early development in rats.

Authors:  G L Holmes; M Sarkisian; Y Ben-Ari; N Chevassus-Au-Louis
Journal:  J Comp Neurol       Date:  1999-02-22       Impact factor: 3.215

6.  Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: an intracellular study of identified pyramidal neurones.

Authors:  G Sancini; S Franceschetti; G Battaglia; C Colacitti; M Di Luca; R Spreafico; G Avanzini
Journal:  Neurosci Lett       Date:  1998-05-01       Impact factor: 3.046

Review 7.  The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): one gene leads to many phenotypes.

Authors:  Elliott H Sherr
Journal:  Curr Opin Pediatr       Date:  2003-12       Impact factor: 2.856

8.  Altered connections between neocortical and heterotopic areas in methylazoxymethanol-treated rat.

Authors:  C Colacitti; G Sancini; S Franceschetti; F Cattabeni; G Avanzini; R Spreafico; M Di Luca; G Battaglia
Journal:  Epilepsy Res       Date:  1998-09       Impact factor: 3.045

9.  Thalidomide is an inhibitor of angiogenesis.

Authors:  R J D'Amato; M S Loughnan; E Flynn; J Folkman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol.

Authors:  N Chevassus-au-Louis; Y Ben-Ari; M Vergnes
Journal:  Brain Res       Date:  1998-11-23       Impact factor: 3.252

View more
  6 in total

Review 1.  Blood-brain barrier, bulk flow, and interstitial clearance in epilepsy.

Authors:  Nicola Marchi; Manoj Banjara; Damir Janigro
Journal:  J Neurosci Methods       Date:  2015-06-18       Impact factor: 2.390

Review 2.  WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?

Authors:  Sergiusz Jozwiak; Albert Becker; Carlos Cepeda; Jerome Engel; Vadym Gnatkovsky; Gilles Huberfeld; Mehmet Kaya; Katja Kobow; Michele Simonato; Jeffrey A Loeb
Journal:  Epilepsia       Date:  2017-04-07       Impact factor: 5.864

Review 3.  Cerebrovascular remodeling and epilepsy.

Authors:  Nicola Marchi; Mireille Lerner-Natoli
Journal:  Neuroscientist       Date:  2012-10-16       Impact factor: 7.519

4.  The etiological role of blood-brain barrier dysfunction in seizure disorders.

Authors:  Nicola Marchi; William Tierney; Andreas V Alexopoulos; Vikram Puvenna; Tiziana Granata; Damir Janigro
Journal:  Cardiovasc Psychiatry Neurol       Date:  2011-03-30

5.  Progressive brain damage, synaptic reorganization and NMDA activation in a model of epileptogenic cortical dysplasia.

Authors:  Francesca Colciaghi; Adele Finardi; Paola Nobili; Denise Locatelli; Giada Spigolon; Giorgio Stefano Battaglia
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

6.  Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation.

Authors:  Hideki Ando; Tomomi Sato; Takumi Ito; Junichi Yamamoto; Satoshi Sakamoto; Nobuhiro Nitta; Tomoko Asatsuma-Okumura; Nobuyuki Shimizu; Ryota Mizushima; Ichio Aoki; Takeshi Imai; Yuki Yamaguchi; Arnold J Berk; Hiroshi Handa
Journal:  iScience       Date:  2019-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.